Page last updated: 2024-08-24

aripiprazole and Deficiency, Mental

aripiprazole has been researched along with Deficiency, Mental in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (38.46)	29.6817
2010's	6 (46.15)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Anand, G; Lee, J; Shepperd, R; Smith, M	1
Garel, N; Joober, R	1
Dinnissen, M; Hoekstra, PJ; Popma, A; Reijnen, S; Reurts, EE; Troost, PW	1
Devriendt, K; Lambrechts, S; Vogels, A	1
Muquebil Ali Al Shaban Rodríguez, OW; Pérez Castro, P	1
Arshad, E; Deb, S; Deb, T; Farmah, BK; Roy, M; Unwin, GL	1
Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK	1
Marshall, PB; Mellman, TA; Nguyen, SX	1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P	1
Caroff, SN; Hammerman, S; Lam, C	1
Alla, L; Sabaratnam, M; Shastri, M	1
Demb, H; Valicenti-McDermott, MR	1
Lee, C; Lee, CU; Lim, HK; Pae, CU	1

Reviews

2 review(s) available for aripiprazole and Deficiency, Mental

Article	Year
The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review. Research in developmental disabilities, 2014, Volume: 35, Issue:3 Topics: Aggression; Antipsychotic Agents; Aripiprazole; Child Development Disorders, Pervasive; Developmental Disabilities; Humans; Intellectual Disability; Mental Disorders; Piperazines; Quinolones; Self-Injurious Behavior; Treatment Outcome	2014
[Medication-related oculogyric crises: a description of four cases and a review of the literature]. Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3 Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid	2013

Article

Year

The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.

Research in developmental disabilities, 2014, Volume: 35, Issue:3

Topics: Aggression; Antipsychotic Agents; Aripiprazole; Child Development Disorders, Pervasive; Developmental Disabilities; Humans; Intellectual Disability; Mental Disorders; Piperazines; Quinolones; Self-Injurious Behavior; Treatment Outcome

2014

Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3

Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid

2013

Other Studies

11 other study(ies) available for aripiprazole and Deficiency, Mental

Article	Year
Recognising side effects of antipsychotics in children with intellectual disabilities. BMJ case reports, 2023, Jan-04, Volume: 16, Issue:1 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Intellectual Disability; Risperidone	2023
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency Journal of psychiatry & neuroscience : JPN, 2019, Nov-01, Volume: 44, Issue:6 Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome	2019
Aripiprazole in youth with intellectual disabilities: A retrospective chart study. Journal of intellectual disabilities : JOID, 2021, Volume: 25, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Intellectual Disability; Piperazines; Quinolones; Retrospective Studies	2021
Low-Dose Aripiprazole and Risperidone for Treating Problem Behavior in Children With Pitt-Hopkins Syndrome. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:3 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Facies; Female; Humans; Hyperventilation; Intellectual Disability; Problem Behavior; Risperidone	2018
[Aripiprazole in the treatment of patients with intellectual disability and elevated prolactin levels]. Semergen, 2019, Volume: 45, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Humans; Intellectual Disability; Prolactin	2019
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism : the international journal of research and practice, 2015, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult	2015
Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine. The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benztropine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Olanzapine; Piperazines; Quinolones; Risk Factors	2008
Neuroleptic malignant syndrome and aripiprazole. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6 Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Humans; Intellectual Disability; Lorazepam; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; United States	2006
Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series. Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6 Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenia, Paranoid	2006
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5 Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders	2006
Tardive dystonic symptoms associated with aripiprazole treatment. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Comorbidity; Dyskinesia, Drug-Induced; Dystonia; Humans; Intellectual Disability; Male; Ocular Motility Disorders; Piperazines; Quinolones; Schizophrenia	2008